Preclinical Evaluation of Nerolidol Suspension and its Nano Lipid Carrier Against Cyclophosphamide Induced Organ Toxicity

dc.contributor.guide	Syed Ehtaishamul Haque and Javed Ali and Najmi, Abul Kalam
dc.coverage.spatial
dc.creator.researcher	Iqubal, Ashif
dc.date.accessioned	2021-10-02T12:22:46Z
dc.date.available	2021-10-02T12:22:46Z
dc.date.awarded	2021
dc.date.completed	2021
dc.date.registered	2017
dc.description.abstract	newline
dc.description.note
dc.format.accompanyingmaterial	DVD
dc.format.dimensions
dc.format.extent	xviii, 176
dc.identifier.uri	http://hdl.handle.net/10603/342977
dc.language	English
dc.publisher.institution	Department of Pharmacology
dc.publisher.place	Delhi
dc.publisher.university	Jamia Hamdard University
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Clinical Pre Clinical and Health
dc.subject.keyword	Pharmacology and Pharmacy
dc.subject.keyword	Pharmacology and Toxicology
dc.title	Preclinical Evaluation of Nerolidol Suspension and its Nano Lipid Carrier Against Cyclophosphamide Induced Organ Toxicity
dc.title.alternative
dc.type.degree	Ph.D.